首页|β-arrestin2在心血管疾病中的研究进展

β-arrestin2在心血管疾病中的研究进展

扫码查看
β-抑制蛋白2(β-arrestin2)是一类具有多种生物学功能的细胞内蛋白质,不仅能够通过与G蛋白竞争性结合G蛋白偶联受体(G protein-coupled receptor,GPCR)从而负性调控GPCR信号通路,还可通过G蛋白非依赖性途径参与调节多种信号转导通路,对心血管系统的稳定至关重要.此外,β-arrestin2异常的表达与高血压、心力衰竭、心肌缺血再灌注损伤、心室重塑、动脉粥样硬化以及动脉瘤等多种疾病密切相关.因此,本文就β-arrestin2在心血管疾病领域的研究进展进行综述,阐述β-arrestin2结构、功能及其在炎症反应、细胞代谢中的作用和相关分子机制,以期为心血管疾病诊治提供新的思路.
Research progress of β-arrestin2 in cardiovascular disease
β-arrestin2 is a kind of intracellular protein with multiple biological functions.It can not only negatively regulate GPCR signal pathway by competitively binding to G protein-coupled receptor(GPCR)with G protein,but also participate in regulating multiple signal transduction pathways through G protein independent pathways,which is critical to the stability of cardiovascular system.In addition,the abnormal expression of β-arrestin2 is associated with hypertension,heart failure,myocardial ischemia-reperfusion injury,ventricular remodeling,arteriosclerosis and aneurysm.This paper introduces the research progress of β-arrestin2 in the field of cardiovascular disease,and expounds the structure,function,role and related molecular mechanism of β-arrestin2 in inflammatory reaction and cell metabolism,aiming to provide new ideas and methods for the prevention and treatment of cardiovascular diseases.

β-arrestin2G protein coupled receptorscardiovascular disease

唐荣杰、赵伟、张瑶、霍迎新、廉秋芳

展开 >

延安大学咸阳医院心血管内科,咸阳 712000

延安大学医学院,延安 716000

β-抑制蛋白2 G蛋白偶联受体 心血管疾病

国家自然科学基金项目陕西省重点研发计划项目

821600902023-YBSF-636

2023

生命的化学
中国生物化学与分子生物学会

生命的化学

CSTPCD
影响因子:0.404
ISSN:1000-1336
年,卷(期):2023.43(10)
  • 3